Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Metabolic Syndrome
NCT02113241Phase 3Completed
- Sponsor
- Universidad de Guadalajara
- Start
- Apr 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin in metabolic syndrome, sponsored by Universidad de Guadalajara. Started Apr 2014; status: completed.
02
Drugs
dapagliflozin
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT02113241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02113241.